171
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

Colon targeted dosage form of Capecitabine using folic acid anchored modified carbon nanotube: in vitro cytotoxicity, apoptosis and in vivo roentgenographic study

ORCID Icon, , , , ORCID Icon &
Pages 1401-1412 | Received 30 Apr 2021, Accepted 09 Oct 2021, Published online: 26 Oct 2021

References

  • Krishnaiah YSR, Satyanarayana V, Dinesh Kumar B, et al. In vitro drug release studies on guar gum-based colon targeted oral drug delivery systems of 5-fluorouracil. Eur J Pharm Sci. 2002;16(3):185–192.
  • Ren Y, Jiang L, Yang S, et al. Design and preparation of a novel colon-targeted tablet of hydrocortisone. Braz J Pharm. 2017;53:15009.
  • Gadhave M, Shevante T, Takale A, et al. Formulation and evaluation of colon targeted drug delivery of mesalamine. Int J Pharm Clin Res. 2017;9:26–34.
  • Shoemaker LK, Arora U, Max SC, et al. 5-Fluorouracil-induced coronary vasospasm. Contr. 2004;11:46–49.
  • Diasio RB, Harris BE. Clinical pharmacology of 5-fluorouracil. Clin Pharmacokinet. 1989;16(4):215–237.
  • Kevadiya BD, Patel TA, Jhala DD, et al. Layered inorganic nanocomposites: a promising carrier for 5-fluorouracil (5-FU)). Eur J Pharm Biopharm. 2012;81(1):91–101.
  • Jin L, Liu Q, Sun Z, et al. Preparation of 5-fluorouracil/b-cyclodextrin complex intercalated in layered double hydroxide and the controlled drug release properties. Ind Eng Chem Res. 2010;49(22):11176–11181.
  • Parker WB. Enzymology of purine and pyrimidine antimetabolites used in the treatment of cancer. Chem Rev. 2009;109(7):2880–2893.
  • Ishikawa T, Utoh M, Sawada N, et al. Tumor selective delivery of 5-fluorouracil by Capecitabine, a new oral fluoropyrimidine carbamate, in human cancer xenografts. Biochem Pharmacol. 1998;55(7):1091–1097.
  • Miwa M, Ura M, Nishida M, et al. Design of a novel oral fluoropyrimidine carbamate, Capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue. Eur J Cancer. 1998;34(8):1274–1281.
  • Schüller J, Cassidy J, Dumont E, et al. Preferential activation of Capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol. 2000;45(4):291–297.
  • Iijima S. Helical microtubules of graphitic carbon. Nature. 1991;354(6348):56–58.
  • Pastorin G, Kostarelos K, Prato M, et al. Carbon nanotubes: from bench chemistry to promising biomedical applications. J Biomed Nanotechnol. 2005;1:1–10.
  • Alomar M, Alsaadi M, Jassam T, et al. Novel deep eutectic solvent-functionalized carbon nanotubes adsorbent for mercury removal from water. J Colloid Interface Sci. 2017;497:413–421.
  • Galano A. Carbon nanotubes: promising agents against free radicals. Nanoscale. 2010;2(3):373–380.
  • Madani SY, Naderi N, Dissanayake O, et al. A new era of cancer treatment: carbon nanotubes as drug delivery tools. Int J Nanomedicine. 2011;6:2963–2979.
  • Ellison M, Chorney M. Reaction of folic acid with single-walled carbon nanotubes. Surf Sci. 2016;652:300–303.
  • Zhang X, Lingjie M, Qinghua L, et al. Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes. Biomaterials. 2009;30(30):6041–6047.
  • Tan J, Saifullah B, Kura A, et al. Incorporation of levodopa into biopolymer, coating based on carboxylated carbon nanotubes for ph-dependant sustained release drug delivery. Nanomaterials. 2018;8(6):389.
  • Skoog DA, Holler F. Surface characterization by spectroscopy and microscopy, principles of instrumental analysis. Philadelphia: Saunders College Pub.; Orlando, Fla.: Harcourt Brace College Publishers; 5th ed. Vol. 3. 2004. p. 549–552.
  • Gardiner D, Graves PR, Bowley HJ. Practical Raman spectroscopy. Berlin, Heidelberg, New York: Springer-Verlag; 1989. p. 157.
  • Rao A, Eklund P, Bandow S, et al. Evidence for charge transfer in doped carbon nanotube bundles from Raman scattering. Nature. 1997;388(6639):257–259.
  • Hailder A, Mohammed M, Ahmed D. Preparation and characterization of multi walled carbon nanotubes/ag nanoparticles hybrid materials. Int J Eng Res. 2014;5:255–261.
  • Sanga D, Chand T. Formulation, development and evaluation of enteric coated tablets of sodium valproate by using wet granulation. Am J Pharm Tech Res. 2013;3:746–751.
  • Bill B, Graham C. Pharmaceutical production engineering guide; Rugby, Warwickshire, UK: Institution of Chemical Engineers (IChemE); 2003. pp. 126–129.
  • Bhutkar M, Yadav A, Sonawane R, et al. Hard capsules: a suitable alternative to soft gelatin capsules for delivering liquid drugs. Res J Pharm Technol. 2008;03:280–282.
  • Wakure B, Yadav A, Bhatia N, et al. Development of chitosan capsule for colon specific delivery of budesonide. Int J Pharm Sci Res. 2013;8:3239–3249.
  • Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immuno Methods. 1983;65(1–2):55–63.
  • Shejawal KP, Randive DS, Bhinge SD, et al. Jadhav, NR green synthesis of silver and iron nanoparticles of isolated proanthrocynidine: its haracterization, antioxidant, antimicrobial and cytotoxic activities against COLO320DM and HT29. J Genetic Eng Biotech. 2020;18:43.
  • Randive DS, Shejawal KP, Bhinge SD, et al. Green synthesis of gold nanoparticles of isolated citrus bioflavonoid from orange: characterization and in vitro cytotoxicity against colon cancer cellines COLO 320DM and HT29. Ind Dru. 2020; 57(08):61–69.
  • Chavan RR, Bhinge SD, Bhutkar MA, et al. Characterization, antioxidant, antimicrobial and cytotoxic activities of green synthesized silver and iron nanoparticles using alcoholic blumea eriantha DC plant extract. Mat Today Comm. 2020;24:101320.
  • Shejawal KP, Randive DS, Bhinge SD, et al. Green synthesis of silver, iron and gold nanoparticles of lycopene extracted from tomato: their characterization and cytotoxicity against COLO320DM, HT29 and hella cell. J Mater Sci Mater Med. 2021;32(2):19.
  • Dev RK, Bali V, Pathak K. Novel microbially triggered Colon specific delivery system of 5-fluorouracil: statistical optimization, in vitro, in vivo, cytotoxic and stability assessment. Int J Pharm. 2011;411(1–2):142–151.
  • Son KH, Hong JH, Lee JW. Carbon nanotubes as cancer therapeutic carriers and mediators. Int J Nanomedicine. 2016; 11:5163–5185.
  • Oberdörster E. Manufactured nanomaterials (fullerenes, C60) induce oxidative stress in the brain of juvenile largemouth bass. Environ Health Perspect. 2004;112(10):1058–1062.
  • Bosi S, Ros TD, Spalluto G, et al. Fullerene derivatives: an attractive tool for biological applications. Eur J Med Chem. 2003;38(11–12):913–923.
  • Huang H, Yuan Q, Shah JS, et al. A new family of folate-decorated and carbon nanotube-mediated drug delivery system: Synthesis and drug delivery response. Adv Drug Deliv Rev. 2011;63(14–15):1332–1339.
  • Sangsanoh P, Supaphol P. Stability improvement of electrospun chitosan nanofibrous membranes in neutral or weak basic aqueous solutions. Biomacromolecules. 2006;7(10):2710–2714.
  • Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed. 2011;6:765–774.
  • Yan Y, Wang R, Hu Y, et al. Stacking of doxorubicin on folic acid-targeted multiwalled carbon nanotubes for in vivo chemotherapy of tumors. Drug Deliv. 2018;25(1):1607–1616.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.